Processa Pharmaceuticals, Inc.

Q2 2024 13F Holders

Symbol
PCSA
CUSIP
74275C304
Type
Equity
Class
COM SHS
Num filings
10
Total reported value, excl. options
$101 k
Manager Report Date Value ($000) Shares Option Type